Child Psychiatry Group Silences Advocates for Child Sex Changes at Annual Conference

The American Academy of Child and Adolescent Psychiatry (AACAP) has rejected multiple panels featuring leading European psychologists discussing Europe's move away from chemical interventions for children with gender dysphoria, raising concerns about the politicization of American medicine and highlighting a clinical divide between the United States and much of the world. The panels would have presented data on the more cautious treatment approach taken by Finland, Sweden, and England, which restrict access to puberty blockers and cross-sex hormones. The rejection of these panels suggests a lack of willingness to consider alternative viewpoints within the AACAP, and raises questions about the influence of activist doctors on medical consensus.